Now Is the Time to Profit from the Largest Marijuana Merger in History

Marijuana investors are anxiously awaiting a colossal marijuana merger.

marijuana merger

Last week, Canada-based medical marijuana producer Aurora Cannabis Inc. (OTCMKTS: ACBFF) made an unsolicited, all-stock hostile takeover bid for fellow medical marijuana company CanniMed Therapeutics (OTCMKTS: CMMDF). With a value just over $2 billion, this would be the largest marijuana merger in history if it comes to fruition.

Aurora has been a part of Money Morning Director of Technology & Venture Capital Research - and pot stock expert - Michael Robinson's model pot stock portfolio since September 2016. Since then, it's shot up 772.6%.

Editor's Note: Aurora is just one of the fundamental picks in Michael's Roadmap to Marijuana Millions model portfolio. Learn how to gain access to the entire portfolio here.

CanniMed shareholders would have plenty of reason to celebrate if this deal were to go through: The proposal price of $24 per share represents a nearly 20% premium to the Nov. 27 closing price.

Aurora investors are also excited. The deal would grant the Aurora-CanniMed mega-company unprecedented production power and market share, which would send Aurora's stock price higher still.

What's more, this merger would bring another round of double- and triple-digit gains for the 30 stocks in our exclusive "weed investors' bible."

Here's why we expect this deal to go through - and how you can profit...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Joining Forces Is a Good Thing for the Companies - and Their Shareholders

CanniMed has been trying to grow its business for the past few years, but it's still a relatively small player in an industry that's dominated by less than a half dozen mega-companies in Canada.

The company reported $4 million in net losses through the first half of fiscal 2017, according to filings, and it was barely delivering positive earnings before interest, taxes, depreciation, and amortization (EBITDA).

Given the company's modest success in an industry ruled by titans, selling for a nice 20% premium should sound pretty good to shareholders.

Join us for this special FREE event: As soon as California fully legalizes cannabis across the state, you could see a handful of tiny penny stocks soar. Gains could exceed 15,251%.  Click here for all the details - including the best California pot stocks to invest in right now.  

What's more, Aurora is unlikely to back down; CanniMed has a lot to offer. It exceeded 14,000 active medical cannabis patients, according to its Q2 report in June - up from 11,000 in February.

And according to Business Insider, roughly half of the company's sales are derived from cannabis oil, which is great for margins. Cannabis oils are priced higher than dried marijuana, increasing weed companies' bottom lines.

With Canada's upcoming total legalization on the horizon, a merger would allow Aurora to potentially claim a larger share of the massive Canadian market. Combining forces would create a company capable of producing 130,000 kilograms of dried cannabis each year and give the duo a medical patient base of around 40,000. But the real strength of this merger will trickle down to benefit smaller companies, like the ones we've been telling you about for the past few months...

These Little-Known Stocks Are on Fire

This time last year, Michael published his first "weed investors' bible." At the time, it was packed with 30 of his absolute favorite plays in the still-booming legal cannabis sector.

Over the past year, this section of the Nova-X Report portfolio has seen 10 double-digit winners and eight triple-digit winners... 291% gains... 193.3%... 189.5%; one recommendation even saw peak gains of 1,588%.

Since then, weed investing's only gotten bigger, better, and more profitable - and we're just at the beginning. As companies like Aurora get stronger and more profitable, production will continue to increase, which will benefit the industry as a whole.

And some pot stock investors will be in the perfect spot to profit. But only if they're looking at the right stocks. We can help with that.

For the last eight months, Michael and his team have dedicated thousands of man hours and over $250,000 toward the most exhaustive analysis of the marijuana industry to date.

He's met with leading growers, dispensaries, angel investors...

And he's vetted the next generations of weed stocks that are poised to make marijuana investors rich.

They're all in his updated 89-page "bible of weed investing," The Roadmap to Marijuana Millions: Phase II. And, for a limited time, you can get all the details for free. Go here to find out how to reserve your copy today...

Follow Money Morning on Twitter @moneymorningFacebook, and LinkedIn.